Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP614249.RAJtBwM5_k4D6DVIJyiM2qjjlid0Jqi70jG82Ji7OvMOY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP614249.RAJtBwM5_k4D6DVIJyiM2qjjlid0Jqi70jG82Ji7OvMOY130_assertion type Assertion NP614249.RAJtBwM5_k4D6DVIJyiM2qjjlid0Jqi70jG82Ji7OvMOY130_head.
- NP614249.RAJtBwM5_k4D6DVIJyiM2qjjlid0Jqi70jG82Ji7OvMOY130_assertion description "[Inhibitors of the tyrosine kinase receptors, such as IGF-1R, c-kit, PDGFR, VEGFR, or the mTOR signaling pathway, proteasome, angiogenesis, and stress response proteins are under clinical evaluation against sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614249.RAJtBwM5_k4D6DVIJyiM2qjjlid0Jqi70jG82Ji7OvMOY130_provenance.
- NP614249.RAJtBwM5_k4D6DVIJyiM2qjjlid0Jqi70jG82Ji7OvMOY130_assertion evidence source_evidence_literature NP614249.RAJtBwM5_k4D6DVIJyiM2qjjlid0Jqi70jG82Ji7OvMOY130_provenance.
- NP614249.RAJtBwM5_k4D6DVIJyiM2qjjlid0Jqi70jG82Ji7OvMOY130_assertion SIO_000772 19013896 NP614249.RAJtBwM5_k4D6DVIJyiM2qjjlid0Jqi70jG82Ji7OvMOY130_provenance.
- NP614249.RAJtBwM5_k4D6DVIJyiM2qjjlid0Jqi70jG82Ji7OvMOY130_assertion wasDerivedFrom befree-20150227 NP614249.RAJtBwM5_k4D6DVIJyiM2qjjlid0Jqi70jG82Ji7OvMOY130_provenance.
- NP614249.RAJtBwM5_k4D6DVIJyiM2qjjlid0Jqi70jG82Ji7OvMOY130_assertion wasGeneratedBy ECO_0000203 NP614249.RAJtBwM5_k4D6DVIJyiM2qjjlid0Jqi70jG82Ji7OvMOY130_provenance.